| Flavones: An important scaffold for medicinal chemistry M Singh, M Kaur, O Silakari European journal of medicinal chemistry 84, 206-239, 2014 | 594 | 2014 |
| Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection M Singh, M Kaur, H Kukreja, R Chugh, O Silakari, D Singh European journal of medicinal chemistry 70, 165-188, 2013 | 409 | 2013 |
| Thiazolidine-2, 4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions N Chadha, MS Bahia, M Kaur, O Silakari Bioorganic & Medicinal Chemistry 23 (13), 2953-2974, 2015 | 115 | 2015 |
| Purinergic receptor P2X7: a novel target for anti-inflammatory therapy N Mehta, M Kaur, M Singh, S Chand, B Vyas, P Silakari, MS Bahia, ... Bioorganic & medicinal chemistry 22 (1), 54-88, 2014 | 112 | 2014 |
| Hybrids: a new paradigm to treat Alzheimer’s disease M Singh, M Kaur, N Chadha, O Silakari Molecular diversity 20, 271-297, 2016 | 96 | 2016 |
| Inhibitors of switch kinase ‘spleen tyrosine kinase’in inflammation and immune-mediated disorders: a review M Kaur, M Singh, O Silakari European journal of medicinal chemistry 67, 434-446, 2013 | 65 | 2013 |
| Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory-and immune-related disorders MS Bahia, M Kaur, P Silakari, O Silakari Cellular signalling 27 (6), 1039-1055, 2015 | 52 | 2015 |
| Benzimidazoles: an ideal privileged drug scaffold for the design of multitargeted anti-inflammatory ligands G Kaur, M Kaur, O Silakari Mini reviews in medicinal chemistry 14 (9), 747-767, 2014 | 48 | 2014 |
| Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10 (9H)-yl)-N-phenyl acetamides R Kumar, M Kaur, MS Bahia, O Silakari European Journal of Medicinal Chemistry 80, 83-91, 2014 | 48 | 2014 |
| Designing of new multi-targeted inhibitors of spleen tyrosine kinase (Syk) and zeta-associated protein of 70 kDa (ZAP-70) using hierarchical virtual screening protocol M Kaur, A Kumari, MS Bahia, O Silakari Journal of Molecular Graphics and Modelling 39, 165-175, 2013 | 36 | 2013 |
| Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore-and docking-based virtual screening approach H Jasuja, N Chadha, M Kaur, O Silakari Molecular diversity 18, 253-267, 2014 | 35 | 2014 |
| Benzimidazole–ibuprofen/mesalamine conjugates: Potential candidates for multifactorial diseases Y Bansal, M Kaur, O Silakari European Journal of Medicinal Chemistry 89, 671-682, 2015 | 33 | 2015 |
| Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions M Kaur, MS Bahia, O Silakari European journal of pharmaceutical sciences 47 (3), 574-588, 2012 | 27 | 2012 |
| Insight into the therapeutic aspects of ‘Zeta-Chain Associated Protein Kinase 70 kDa’inhibitors: A review M Kaur, M Singh, O Silakari Cellular signalling 26 (11), 2481-2492, 2014 | 20 | 2014 |
| Pharmacophore and docking-based hierarchical virtual screening for the designing of aldose reductase inhibitors: synthesis and biological evaluation B Vyas, M Singh, M Kaur, O Silakari, MS Bahia, B Singh Medicinal Chemistry Research 25, 609-626, 2016 | 19 | 2016 |
| Exploring the role of water molecules for docking and receptor guided 3D-QSAR analysis of naphthyridine derivatives as spleen tyrosine kinase (Syk) inhibitors M Kaur, MS Bahia, O Silakari Journal of chemical information and modeling 52 (10), 2619-2630, 2012 | 18 | 2012 |
| Aldose reductase inhibitors for diabetic complications: Receptor induced atom-based 3D-QSAR analysis, synthesis and biological evaluation B Vyas, M Singh, M Kaur, MS Bahia, AS Jaggi, O Silakari, B Singh Journal of Molecular Graphics and Modelling 59, 59-71, 2015 | 16 | 2015 |
| Chemistry and biological activities of thioacridines/thioacridones R Kumar, M Kaur, O Silakari Mini reviews in medicinal chemistry 13 (8), 1220-1230, 2013 | 16 | 2013 |
| Integrated pharmacophore and docking‐based designing of dual inhibitors of aldose reductase (ALR2) and protein tyrosine phosphatase 1B (PTP1B) as novel therapeutics for insulin … B Vyas, O Silakari, M Kaur, B Singh Journal of Chemometrics 29 (2), 109-125, 2015 | 8 | 2015 |
| Pharmacophore and docking-based virtual screening approach for the design of new dual inhibitors of Janus kinase 1 and Janus kinase 2 H Jasuja, N Chadha, M Kaur, O Silakari SAR and QSAR in Environmental Research 25 (8), 617-636, 2014 | 7 | 2014 |
